Herpes simplex virus: the importance of asymptomatic shedding.
about
Prevention of genital herpes in a guinea pig model using a glycoprotein D-specific single chain antibody as a microbicideOptimal management of genital herpes: current perspectivesRecent advances in vaccine development for herpes simplex virus types I and IIThe molecular basis of herpes simplex virus latencyInfectious Disease Stigmas: Maladaptive in Modern SocietyLongitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIVMany hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers.Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data.Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies.Up to four distinct polypeptides are produced from the γ34.5 open reading frame of herpes simplex virus 2Skin manifestations of athletes competing in the summer olympics: what a sports medicine physician should know.Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster.Herpes simplex and varicella zoster viruses: forgotten but not gone.Antifungal and antiviral chemotherapy.Progress in meeting today's demands in genital herpes: an overview of current management.Patient and physician partnerships in managing genital herpes.Clinical manifestations and treatment considerations of herpes simplex virus infection.Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces.Herpes misdiagnosed as pyoderma gangrenosumSingle and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal modelsDiagnosis of genital herpes by real time PCR in routine clinical practice.Sexually transmitted herpes simplex viruses.Incentivising safe sex: a randomised trial of conditional cash transfers for HIV and sexually transmitted infection prevention in rural TanzaniaResistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanismChanges in the soluble mucosal immune environment during genital herpes outbreaks.Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes.Virus-encoded b7-2 costimulation molecules enhance the protective capacity of a replication-defective herpes simplex virus type 2 vaccine in immunocompetent mice.Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1.Suppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy?A Comparative Analysis of Polymerase Chain Reaction and Direct Fluorescent Antibody Test for Diagnosis of Genital HerpesSilencing sexually transmitted infections: topical siRNA-based interventions for the prevention of HIV and HSVHerpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options.Overexpression and purification of HSV-2 glycoprotein D in suspension CHO cells with serum-free medium and immunogenicity analysis.Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency.
P2860
Q24803342-E058C1D0-CF9C-4027-B190-3CDD3A367B9FQ26746041-71466B13-8CF7-47CB-83D0-E0ED81BEF87BQ26859623-048AC461-E23E-487B-A797-32D4F6814199Q27001272-7609B6E4-072F-4496-A072-BBADB53DDBB7Q28650636-0A7444FA-0749-4C25-B5BD-ACA997B0853BQ28660303-AB8C4BFC-BBB0-422E-AD5A-AE1A6F5263DAQ30884457-E396EDA8-6100-43D9-8124-7973BDE73145Q33550768-2F260932-E0D5-441D-AEB1-7291E68D0AA5Q33750736-1C921037-8755-43F4-918F-1EB6BB4C912AQ34081662-C6CF508B-B7AD-4882-896E-740ED50AB2D6Q34141544-2476E139-4E0D-4F55-A605-542E012C970FQ34142834-69D99A96-99E4-4525-A71D-D0A9ACB733D4Q34261842-FC5259A3-2243-4136-917D-48DF640C4EC5Q34268978-2E442CFB-D250-46FC-B2F1-B6024BAFD28CQ34356255-218C2663-E94E-40D1-92B0-25EABBEE44FEQ34551831-9B85498A-EF45-4B2A-95FD-324EBB3ADE83Q34613055-5780F547-89B9-4D45-BB08-D748A00B1689Q34639628-2F4BFA2D-9A46-4822-A38A-4EF1A4315C08Q34918299-854AD5AA-EF05-426A-B3B8-E31AE9D27FACQ34918316-16417B22-81EA-4730-9996-CF619FDFB7BAQ34918343-23F39C6E-956E-43BB-990A-458F7B5FA9C6Q35042478-160510B5-8FEA-42FE-AD23-938F86D639EEQ35199543-D3002019-C7C6-4786-B66E-D75CAAF0670AQ35271194-8D6A3D30-6666-4B47-9FA3-2DC0A30A44EEQ35531465-CF0C420A-0201-4D44-8118-C3055C6F097CQ35733995-C143AF7F-B284-45F1-9998-FEF56C8FF5D1Q35899457-665D1619-274E-4DAF-B306-0354698833B8Q35923346-1A266780-2ED7-445A-932D-3121F1A41CE5Q36555158-E259569A-790C-48D5-8199-C99F8518A73BQ36898823-426BDDE8-D064-443C-A32A-A44D2B5E1E87Q36937188-57F468B8-99FA-45B5-964B-45EE1B257EA2Q36978882-9FD77C09-BEB6-4D70-A90A-D8BA3FEBE651Q37033377-F2B225A2-5DFE-4D91-8A87-C0EFF4DF08D2Q37059943-731331F1-5BA0-4733-9158-EE0C3ADA4E52Q37206230-077D6449-4F50-4283-91EB-59164FA61E4AQ37241057-164F20A3-85C5-4F71-8373-6A7C83E3E4E4Q37553822-3C475423-A3AC-4AE3-84D6-BF2CE23DB65CQ37771396-09E33F76-F5DE-43BA-A02C-7E9A6B4CCAABQ38883116-0409F611-E079-4513-BAF1-7B4ED112BDA6Q39394174-4F77415D-2261-49F6-9A58-3EE0AC493C21
P2860
Herpes simplex virus: the importance of asymptomatic shedding.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Herpes simplex virus: the importance of asymptomatic shedding.
@ast
Herpes simplex virus: the importance of asymptomatic shedding.
@en
type
label
Herpes simplex virus: the importance of asymptomatic shedding.
@ast
Herpes simplex virus: the importance of asymptomatic shedding.
@en
prefLabel
Herpes simplex virus: the importance of asymptomatic shedding.
@ast
Herpes simplex virus: the importance of asymptomatic shedding.
@en
P356
P1476
Herpes simplex virus: the importance of asymptomatic shedding.
@en
P2093
P356
10.1093/JAC/45.SUPPL_4.1
P407
P478
45 Suppl T3
P577
2000-04-01T00:00:00Z